febuxostat has been researched along with Stevens-Johnson Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tana, T; Vadas, P | 1 |
| Chang, JY; Chin, SW; Chu, MT; Chung, WH; Huang, YL; Hung, SI; Pan, RY; Wang, WC | 1 |
3 other study(ies) available for febuxostat and Stevens-Johnson Syndrome
| Article | Year |
|---|---|
Febuxostat Desensitization in a Patient with Previous Stevens-Johnson Syndrome and
Topics: Adult; Febuxostat; Genotype; Gout; HLA-B Antigens; Humans; Male; Stevens-Johnson Syndrome | 2019 |
Oxypurinol-Specific T Cells Possess Preferential TCR Clonotypes and Express Granulysin in Allopurinol-Induced Severe Cutaneous Adverse Reactions.
Topics: Adult; Aged; Aged, 80 and over; Allopurinol; Antigens, Differentiation, T-Lymphocyte; Case-Control Studies; Cells, Cultured; Cross Reactions; Drug Eruptions; Enzyme-Linked Immunosorbent Assay; Febuxostat; Female; Humans; Interferon-gamma; Leukocytes, Mononuclear; Lymphocyte Activation; Male; Middle Aged; Oxypurinol; Reference Values; Stevens-Johnson Syndrome; Thiazoles | 2015 |
Febuxostat (Adenuric). Toxic epidermal necrolysis and severe hypersensitivity reactions added to the EU SPC.
Topics: Drug Hypersensitivity Syndrome; Febuxostat; Gout Suppressants; Humans; Risk Assessment; Risk Factors; Severity of Illness Index; Stevens-Johnson Syndrome; Thiazoles | 2015 |